(IN BRIEF) AstraZeneca and Daiichi Sankyo announced that their drug Enhertu (trastuzumab deruxtecan) has been granted Priority Review by the US FDA for treating patients with unresectable or metastatic HER2-low or HER2-ultralow breast cancer who have previously undergone endocrine therapy. … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AstraZeneca, Breast Cancer Patients, Daiichi Sankyo, HER2-Low, Ken Takeshita, partnership, Pre-Chemotherapy, safety, Susan Galbraith, sustainability, Ultralow
(IN BRIEF) The European Investment Bank (EIB) and CriteriaCaixa have signed an €80 million loan agreement to finance the construction of the CaixaResearch Institute in Barcelona. This interdisciplinary research center, spearheaded by “la Caixa” Foundation, will focus on immunology and … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Luxembourg, Management, News, Science, Spain, Technology
Tagged Ángel Simón, Antonio Vila, CaixaResearch Institute, EIB, Immunology Research Center, Jean-Christophe Laloux, partnership, Spain, sustainability
(IN BRIEF) Researchers from LMU have discovered that CD8-positive T cells, a type of immune cell, play a crucial role in the early stages of multiple sclerosis (MS). By studying identical twins, where one twin has MS and the other … Read the full press release
Posted in Business, Education, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged CD8-positive T cells, Diagnosing, Immune System Signals, LMU Munich, multiple sclerosis, Preventing, wellbeing
(IN BRIEF) Fresenius Kabi, in collaboration with Formycon, has received approval from the European Commission (EC) for FYB202, a biosimilar of ustekinumab (marketed as Stelara® by Johnson & Johnson). This biosimilar is approved for the treatment of serious inflammatory diseases. … Read the full press release
Posted in Business, Environment, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Formycon, Fresenius Kabi, FYB202, partnership, safety, Stelara®, sustainability, Ustekinumab Biosimilar
(IN BRIEF) Fresenius Kabi, in partnership with Formycon AG, has received European Commission approval for Otulfi®, a biosimilar of ustekinumab. This new product, authorized for both subcutaneous and intravenous formulations, will treat inflammatory conditions such as Crohn’s disease, plaque psoriasis, … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Dr. Sang-Jin Pak, Formycon AG, Fresenius Kabi, inflammatory diseases, Otulfi®, partnership, safety, sustainability, Ustekinumab Biosimilar
(IN BRIEF) SCHOTT Pharma, Gerresheimer, and Stevanato Group have formed the “Alliance for RTU” to promote the adoption of ready-to-use (RTU) vials and cartridges within the pharmaceutical industry. This strategic alliance aims to streamline pharmaceutical manufacturing, improve operational efficiency, and … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Alliance for RTU, cartridges, Gerresheimer, partnership, Ready-to-Use Packaging Solutions, safety, SCHOTT Pharma, Stevanato Group, sustainability, vials
(IN BRIEF) Roche has announced positive results from its phase III REGENCY study, showing that its drug Gazyva®/Gazyvaro® (obinutuzumab) significantly outperformed standard therapy in treating active lupus nephritis. The study found that patients receiving Gazyva/Gazyvaro, in combination with standard therapies, … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Dr. Brad H. Rovin, Gazyva, kidney disease patients, Levi Garraway, lupus nephritis, Roche, safety
(IN BRIEF) Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European Medicines Agency’s (EMA) CHMP for use in individuals aged six months and older. Pending final approval from the European Commission, the vaccine will … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged BioNTech, COVID-19 vaccine, New York, Omicron KP.2, partnership, Pfizer, safety, sustainability
(IN BRIEF) FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making it the first flu vaccine of its kind to be used at home. Adults up to 49 years old … Read the full press release
(IN BRIEF) At the 79th United Nations General Assembly, European Investment Bank (EIB) President Nadia Calviño will announce new initiatives focused on global health and climate finance. The EIB, in collaboration with partners like the Gates Foundation and WHO, will … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Government, Healthcare, Industrial, Investment, Luxembourg, Management, Media, News
Tagged 79th United Nations General Assembly (UNGA), Ambroise Fayolle, Climate Initiatives, Dr. Tedros Ghebreyesus, European Investment Bank, Gabriel Boric, Gates Foundation, global health, Healthcare, Marina Silva, Mia Amor Mottley, Multilateral Development Banks (MDBs), Nadia Calviño, New York, partnership, sustainability, Thomas Östros, UN General Assembly, WHO
(IN BRIEF) Basilea Pharmaceutica has entered into a multi-year agreement with the Biomedical Advanced Research and Development Authority (BARDA) to support the development of novel antifungal and antibacterial treatments. The agreement provides an initial USD 29 million, with the potential … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Antibacterial Treatments, antifungal, BAL2062, Basilea, Biomedical Advanced Research and Development Authority (BARDA), David Veitch, fosmanogepix, partnership, sustainability, USA
(IN BRIEF) Researchers at Eindhoven University of Technology (TU/e) are developing AI-based solutions to improve the detection and treatment of pancreatic cancer, a highly deadly form of cancer. EngD candidate Victoria Bruno and PhD candidate Terese Hellström are collaborating with … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Environment, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology
Tagged AI, Detection, pancreatic cancer, Terese Hellström, TU/e, Victoria Bruno
(IN BRIEF) Kuehne+Nagel, in partnership with Medtronic, has opened a new temperature-controlled healthcare fulfilment centre in Milton, Ontario. This 25,000 square meter facility will serve as a distribution hub for Medtronic’s medical devices and therapies, supporting hospitals and healthcare institutions … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Switzerland, Technology, Transportation & Logistics
Tagged CANADA, Eduardo Razuck, Healthcare, Kuehne+Nagel, logistics, Mbaye Seye, Medtronic, partnership, sustainability
(IN BRIEF) The Helsingør Sundhedshus health center in Denmark, part of Nordsjællands Hospital, has embraced modern design and sustainability with the installation of 2,500 m² of Lindner RIBline lamella wall and ceiling cladding. This enhances patient wellbeing by creating a … Read the full press release
Posted in Business, Construction, Denmark, Environment, Financial, Germany, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Security & Safety, Technology
Tagged Denmark, Helsingør Sundhedshus, Lindner, modern design, partnership, patient care, RIBline Cladding, safety
(IN BRIEF) AstraZeneca’s Fasenra (benralizumab) has been approved by the US FDA for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA), a rare immune-mediated vasculitis that can be fatal without treatment. The approval is based on results from the MANDARA … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged Adrian Kemp, AstraZeneca, Dr. Michael Wechsler, Eosinophilic Granulomatosis with Polyangiitis (EGPA), Fasenra, FDA, Joyce Kullman, Ruud Dobber, safety, vasculitis
(IN BRIEF) ZEISS Medical Technology will introduce new digital and AI-driven innovations at the EURETINA 2024 conference. Key highlights include the ZEISS ARTEVO 850 3D digital visualization system and the EVA NEXUS surgical system, which enhance precision and safety in … Read the full press release
Posted in Artificial Intelligence (AI), Business, Electronics & Machinery, Financial, Germany, Healthcare, Industrial, Investment, Management, Media, News, Science, Technology
Tagged AI-powered, CIRRUS PathFinder, Diagnostic Innovations, EURETINA 2024, EVA NEXUS surgical system, Retinal Surgery, ZEISS, ZEISS ARTEVO 850 3D digital visualization system
(IN BRIEF) Belgium-based PanTera has raised €134 million in a Series A funding round led by EQT Life Sciences to accelerate the large-scale production of actinium-225 (225Ac), a crucial isotope for Targeted Alpha Therapy (TAT) used in cancer treatment. The … Read the full press release
Posted in Belgium, Business, Environment, Financial, Healthcare, Industrial, Investment, Management, News, Science, Sweden, Technology
Tagged Actinium-225, Belgium, Cancer Therapies, EQT, PanTera, partnership, shortage, sustainabilty
(IN BRIEF) GSK’s depemokimab, a new ultra-long-acting biologic, showed a 54% reduction in severe asthma exacerbations in the SWIFT-1 and SWIFT-2 phase III trials. Administered every six months, it also demonstrated a 72% reduction in hospitalizations and emergency visits, offering … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged David Jackson, Depemokimab, GSK, Phase III Trials, safety, Severe Asthma Attacks, SWIFT-1, SWIFT-2
(IN BRIEF) The Luxembourg Future Fund 2 (LFF 2) has invested an additional €5 million in the VIVES Inter-University Fund (IUF), raising the fund’s total to €75 million. VIVES IUF is an early-stage science-based fund that supports startups and spin-offs, … Read the full press release
Posted in Banks, Belgium, Business, Economy, Education, Environment, Financial, Government, Healthcare, Industrial, Investment, Luxembourg, Management, News, Science, Technology
Tagged EIF, European Innovation, Eva Kremer, investment, Luxembourg Future Fund 2 (LFF 2), Marjut Falkstedt, partnership, Société Nationale de Crédit et d’Investissement (SNCI), Startup Ecosystem, sustainability, VIVES Inter-University Fund (IUF)
(IN BRIEF) AstraZeneca has completed clinical studies to transition Breztri, its inhaled treatment for COPD, to a next-generation propellant with 99.9% lower Global Warming Potential. This change aligns with AstraZeneca’s commitment to reducing its environmental impact through its Ambition Zero … Read the full press release
Posted in Business, Environment, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AstraZeneca, Breztri, COPD, eco-friendly, Honeywell, Low-Impact Inhalers, partnership, Professor Omar Usmani, sustainability
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?